StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca u.S. rebates, chargebacks & returns reserve closing balance ($M) ($M)

Form 20-F Note 2 & Note 19 — U.S. GTN Accrual Rollforward

Latest, FY2025
5,941
Period ended Dec 31, 2025
Change on a year earlier
+19.3%
4,978 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. rebates, chargebacks & returns reserve closing balance ($M) ($M)Year on yearSource
FY2025Dec 31, 20255,941+19.3%Form 20-F FY2025 Annual Report ↗
FY2024Dec 31, 20244,978-2.7%Form 20-F FY2025 Annual Report ↗
FY2023Dec 31, 20235,116+29.2%Form 20-F FY2025 Annual Report ↗
FY2022Dec 31, 20223,961–Form 20-F FY2024 Annual Report ↗

Breakdown

What makes up u.s. rebates, chargebacks & returns reserve closing balance ($m)

Cite this data

StockData. (2026). AstraZeneca U.S. rebates, chargebacks & returns reserve closing balance ($M) ($M), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/us_gtn_accrual_total

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.